CING
CING
NASDAQ · Pharmaceuticals

Cingulate Inc

$5.27
+0.04 (+0.76%)
As of May 9, 9:45 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +172.9% upside
Low Target $9.95
Average Target $14.38
High Target $17.66
Current Price $5.27
Current
$5.27
Target
$14.38
$9.95 $14.38 avg $17.66
Scenario Analysis
Bear Case
$9.95
88.8%
Low target
Base Case
$14.38
+172.9%
Avg target
Bull Case
$17.66
+235.1%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$11.89
-55.7% from high
52-Week Low
$3.20
+64.7% from low
Target vs 52W High
$14.38
+20.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 36 44% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%